Background Glycemic control in diabetes mellitus is a cornerstone in reducing morbidity and
mortality of the disease. Achieving glycemic control or reducing hyperglycemia significantly …

Introduction: Diabetes is often accompanied by undiagnosed dyslipidemia. The aim of the
study is to investigate the clinical relevance of lipid profiles and lipid ratios as predictive …

Background Diabetes is characterized by chronic hyperglycemia and disturbances of
carbohydrate, lipid and protein metabolism. We aimed to research association between …

Background: Patients with type 2 diabetes (T2DM) have an increased prevalence of
dyslipidemia, which contributes to their high risk of cardiovascular diseases (CVDs). This …

Background: Type II Diabetes mellitus (T2DM) is a multifactorial disease and a leading
cause of premature deaths. Inflammatory cytokines are reported that they have potential to …

Background Dyslipidemia is one of the major risk factors for cardiovascular disease in
diabetes mellitus. Early detection and treatment of dyslipidemia in type-2 diabetes mellitus …

Background Dyslipidemia and obesity are the most common complex metabolic disorders
taking the highest toll of health resources globally by its increasing incidences. This …

Tip 2 diyabet hastalarında kan lipid düzeylerinin Hba1c ve obezite ile ilişkisi Amaç:
Dislipidemi, dünyadaki bir numaralı mortalite nedeni olan koroner arter hastalığının (KAH) …

Glycosylated haemoglobin (HbA1c) is a routinely used marker for long-term glycaemic
control. This study aimed to reveal the correlation of HbA1c with BMI and HDL-cholesterol in …

Background A shortened reproductive period and earlier menopause have been associated
with type 2 diabetes. Growth differentiation factor 9 (GDF9) and bone morphogenetic protein …